Cargando…
Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study
Objective To examine a reported association between use of angiotensin converting enzyme (ACE) inhibitors during the first trimester and risk of malformations in offspring. Design A population based, retrospective cohort study linking automated clinical and pharmacy databases including comprehensive...
Autores principales: | Li, De-Kun, Yang, Chunmei, Andrade, Susan, Tavares, Venessa, Ferber, Jeannette R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196564/ https://www.ncbi.nlm.nih.gov/pubmed/22010128 http://dx.doi.org/10.1136/bmj.d5931 |
Ejemplares similares
-
Adverse pregnancy outcomes associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta‐analysis
por: Buawangpong, Nida, et al.
Publicado: (2020) -
Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016) -
Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021) -
Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension
por: Berger, Sigurd, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)